Park Dental Partners (PARK)
Market Price (9/21/2026): $20.32 | Market Cap: $92.9 MilSector: Health Care | Industry: Health Care Facilities
Park Dental Partners (PARK)
Market Price (9/21/2026): $20.32Market Cap: $92.9 MilSector: Health CareIndustry: Health Care Facilities
Investment Highlights Why It Matters Detailed financial logic regarding cash flow yields vs trend-riding momentum.
Attractive yieldFCF Yield is 11% Megatrend and thematic driversMegatrends include Oral Healthcare Innovation. Themes include Digital Dentistry & Patient Engagement, Personalized & Preventative Dental Care, and Geriatric & Specialized Dental Services. | Not profitable at operating income levelOp Inc LTMOperating Income, Last Twelve Months is -7.1 Mil, Op Mgn LTMOperating Margin = Operating Income / Revenue Reflects profitability before taxes and before impact of capital structure (interest payments). is -2.8% Yield minus risk free rate is negativeERPEquity Risk Premium (ERP) = Total Yield - Risk Free Rate, Reflects the premium above risk free assets offered by the investment. is -8.0% Key risksPARK key risks include [1] credit risks from its geographically concentrated dental affiliates, Show more. |
| Attractive yieldFCF Yield is 11% |
| Megatrend and thematic driversMegatrends include Oral Healthcare Innovation. Themes include Digital Dentistry & Patient Engagement, Personalized & Preventative Dental Care, and Geriatric & Specialized Dental Services. |
| Not profitable at operating income levelOp Inc LTMOperating Income, Last Twelve Months is -7.1 Mil, Op Mgn LTMOperating Margin = Operating Income / Revenue Reflects profitability before taxes and before impact of capital structure (interest payments). is -2.8% |
| Yield minus risk free rate is negativeERPEquity Risk Premium (ERP) = Total Yield - Risk Free Rate, Reflects the premium above risk free assets offered by the investment. is -8.0% |
| Key risksPARK key risks include [1] credit risks from its geographically concentrated dental affiliates, Show more. |
Qualitative Assessment
AI Analysis | Feedback
Park Dental Partners (PARK) stock has gained about 5% since 5/31/2026 because of the following key factors:
1. Park Dental Partners significantly exceeded earnings expectations for fiscal Q2 2026, which ended on June 30, 2026. The company reported earnings per share (EPS) of $0.66, substantially surpassing analysts' consensus estimates of $0.04. This strong performance demonstrated robust operational efficiency and contributed positively to investor confidence.
2. The company pursued strategic expansion through acquisitions, enhancing its market presence. Notably, Park Dental Partners announced the acquisition of Village Family Dental Services Organization on August 10, 2026, marking its entry into the North Carolina market. Additionally, it expanded its Rochester, Minnesota network by adding Zumbro View Dental on June 4, 2026. These strategic moves are expected to drive future revenue growth and operational scale.
Show more
Park Dental Partners (PARK) stock has gained about 5% since 5/31/2026 because of the following key factors:
1. Park Dental Partners significantly exceeded earnings expectations for fiscal Q2 2026, which ended on June 30, 2026. The company reported earnings per share (EPS) of $0.66, substantially surpassing analysts' consensus estimates of $0.04. This strong performance demonstrated robust operational efficiency and contributed positively to investor confidence.
2. The company pursued strategic expansion through acquisitions, enhancing its market presence. Notably, Park Dental Partners announced the acquisition of Village Family Dental Services Organization on August 10, 2026, marking its entry into the North Carolina market. Additionally, it expanded its Rochester, Minnesota network by adding Zumbro View Dental on June 4, 2026. These strategic moves are expected to drive future revenue growth and operational scale.
3. Analyst sentiment remained largely positive, with several firms reiterating or upgrading their ratings and price targets. The company holds a consensus "Moderate Buy" rating from Wall Street analysts, with an average price target of $28.50. This target represents a potential upside of approximately 35.3% from recent trading levels, reflecting continued optimism regarding Park Dental Partners' future performance. For example, Craig Hallum reissued a "buy" rating and raised its price target to $30.00.
Show less
Stock Movement Drivers
Fundamental Drivers
The 5.0% change in PARK stock from 5/31/2026 to 9/20/2026 was primarily driven by a 0.0% change in the company's Total Revenues ($ Mil).| (LTM values as of) | 5312026 | 9202026 | Change |
|---|---|---|---|
| Stock Price ($) | 19.38 | 20.34 | 5.0% |
| Change Contribution By: | |||
| Total Revenues ($ Mil) | � | 251 | 0.0% |
| P/S Multiple | � | 0.4 | 0.0% |
| Shares Outstanding (Mil) | 2 | 5 | -61.1% |
| Cumulative Contribution | 0.0% |
Market Drivers
5/31/2026 to 9/20/2026| Return | Correlation | |
|---|---|---|
| PARK | 5.0% | |
| Market (SPY) | 0.9% | 7.3% |
| Sector (XLV) | 12.7% | -2.1% |
Fundamental Drivers
The 7.8% change in PARK stock from 2/28/2026 to 9/20/2026 was primarily driven by a 0.0% change in the company's Total Revenues ($ Mil).| (LTM values as of) | 2282026 | 9202026 | Change |
|---|---|---|---|
| Stock Price ($) | 18.86 | 20.34 | 7.8% |
| Change Contribution By: | |||
| Total Revenues ($ Mil) | � | 251 | 0.0% |
| P/S Multiple | � | 0.4 | 0.0% |
| Shares Outstanding (Mil) | 2 | 5 | -61.1% |
| Cumulative Contribution | 0.0% |
Market Drivers
2/28/2026 to 9/20/2026| Return | Correlation | |
|---|---|---|
| PARK | 7.8% | |
| Market (SPY) | 11.6% | 9.8% |
| Sector (XLV) | 5.5% | 2.7% |
Fundamental Drivers
nullnull
Market Drivers
8/31/2025 to 9/20/2026| Return | Correlation | |
|---|---|---|
| PARK | ||
| Market (SPY) | 19.4% | 8.8% |
| Sector (XLV) | 24.1% | 2.2% |
Fundamental Drivers
nullnull
Market Drivers
8/31/2023 to 9/20/2026| Return | Correlation | |
|---|---|---|
| PARK | ||
| Market (SPY) | 75.6% | 8.8% |
| Sector (XLV) | 32.3% | 2.2% |
Price Returns Compared
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | Total [1] | |
|---|---|---|---|---|---|---|---|
| Returns | |||||||
| PARK Return | - | - | - | - | 44% | 37% | 98% |
| Peers Return | 20% | -33% | 2% | -24% | -10% | -0% | -44% |
| S&P 500 Return | 27% | -19% | 24% | 23% | 16% | 12% | 103% |
Monthly Win Rates [3] | |||||||
| PARK Win Rate | - | - | - | - | 100% | 67% | |
| Peers Win Rate | 50% | 42% | 52% | 40% | 50% | 56% | |
| S&P 500 Win Rate | 75% | 42% | 67% | 75% | 67% | 44% | |
Max Drawdowns [4] | |||||||
| PARK Max Drawdown | - | - | - | - | - | -23% | |
| Peers Max Drawdown | -21% | -48% | -42% | -38% | -39% | -26% | |
| S&P 500 Max Drawdown | -5% | -25% | -10% | -8% | -19% | -9% | |
[1] Cumulative total returns since the beginning of 2021
[2] Peers: HSIC, XRAY, ALGN, NVST.
[3] Win Rate = % of calendar months in which monthly returns were positive
[4] Max drawdown represents maximum peak-to-trough decline within a year
[5] 2026 data is for the year up to 9/18/2026 (YTD)
How Low Can It Go
PARK has limited trading history. Below is the Health Care sector ETF (XLV) in its place.
| Event | XLV | S&P 500 |
|---|---|---|
| 2025 US Tariff Shock | ||
| % Loss | -11.7% | -18.8% |
| % Gain to Breakeven | 13.3% | 23.1% |
| Time to Breakeven | 142 days | 79 days |
| 2022 Inflation Shock & Fed Tightening | ||
| % Loss | -13.8% | -24.5% |
| % Gain to Breakeven | 15.9% | 32.4% |
| Time to Breakeven | 166 days | 427 days |
| 2020 COVID-19 Crash | ||
| % Loss | -27.9% | -33.7% |
| % Gain to Breakeven | 38.8% | 50.9% |
| Time to Breakeven | 77 days | 140 days |
| Q4 2018 Fed Policy Error / Growth Scare | ||
| % Loss | -15.0% | -19.2% |
| % Gain to Breakeven | 17.6% | 23.8% |
| Time to Breakeven | 191 days | 105 days |
| 2015-2016 China Devaluation / Global Growth Scare | ||
| % Loss | -15.9% | -12.2% |
| % Gain to Breakeven | 18.9% | 13.9% |
| Time to Breakeven | 165 days | 62 days |
| 2011 US Debt Ceiling Crisis & European Contagion | ||
| % Loss | -15.8% | -17.9% |
| % Gain to Breakeven | 18.8% | 21.8% |
| Time to Breakeven | 153 days | 123 days |
In The Past
State Street Health Care Select Sector SPDR ETF's stock fell -11.7% during the 2025 US Tariff Shock. Such a loss loss requires a 13.3% gain to breakeven.
Preserve Wealth
Limiting losses and compounding gains is essential to preserving wealth.
Asset Allocation
Actively managed asset allocation strategies protect wealth. Learn more.
PARK has limited trading history. Below is the Health Care sector ETF (XLV) in its place.
| Event | XLV | S&P 500 |
|---|---|---|
| 2020 COVID-19 Crash | ||
| % Loss | -27.9% | -33.7% |
| % Gain to Breakeven | 38.8% | 50.9% |
| Time to Breakeven | 77 days | 140 days |
| 2008-2009 Global Financial Crisis | ||
| % Loss | -37.9% | -53.4% |
| % Gain to Breakeven | 61.1% | 114.4% |
| Time to Breakeven | 767 days | 1085 days |
In The Past
State Street Health Care Select Sector SPDR ETF's stock fell -11.7% during the 2025 US Tariff Shock. Such a loss loss requires a 13.3% gain to breakeven.
Preserve Wealth
Limiting losses and compounding gains is essential to preserving wealth.
Asset Allocation
Actively managed asset allocation strategies protect wealth. Learn more.
About Park Dental Partners (PARK)
Park Dental Partners (PARK) functions as a Dental Resource Organization (DRO), offering comprehensive business support services to a network of 84 affiliated general and multi-specialty dental practices located throughout Minnesota and Wisconsin. These services include providing clinical team members such as hygienists and dental assistants, administrative personnel, as well as facilities and equipment. This model allows affiliated dentists to concentrate solely on delivering patient care. The company's revenues are primarily generated from the wide array of dental services provided by these practices, which cover everything from general dentistry to specialized fields like oral surgery, periodontics, pediatric dentistry, and orthodontics.
A key differentiator for Park Dental Partners is its dentist-majority ownership structure, which ensures affiliated dentists have significant organizational input and governance rights. This approach is designed to attract and retain dental professionals and foster a long-term commitment to patient well-being. The affiliated practices operate under long-term agreements and serve patients primarily through private insurance or government-sponsored plans, which accounted for over 90% of the company's total revenues. Patients are a key focus, with the mission being to ensure they enjoy a lifetime of good oral health.
Park Dental Partners has demonstrated a robust growth trajectory, expanding its footprint through both acquisitions and the opening of new, de novo practices. Since 2014, the company has acquired 40 practices and opened 11 de novo locations, with over 80% of these new practices becoming cash flow positive within approximately six months. For the nine months ended September 30, 2025, the company reported revenues of approximately $183.3 million, building on revenues of $229.8 million for the full year 2024, underscoring its established market presence and effective growth strategy.
AI Analysis | Feedback
1. It's like **Optum (part of UnitedHealth Group)**, but specifically focused on providing comprehensive business support and management services to a large network of affiliated dental practices.
2. Think of it as a **Davita Kidney Care** model, but applied to dental practices: managing a large, growing network of dental clinics by centralizing all the operational and administrative support, allowing dentists to focus on patient care.
AI Analysis | Feedback
-
Comprehensive Dental Services: Park Dental Partners, through its affiliated dental practices, provides a wide range of general and specialty dental treatments to patients. These services are the primary source of the company's revenue.
- General Dentistry: Routine dental care, including examinations, cleanings, fillings, and preventative treatments.
- Oral Surgery: Surgical procedures related to the mouth, teeth, jaws, and facial structures.
- Periodontics: Specializes in the prevention, diagnosis, and treatment of gum disease and other conditions affecting the supporting structures of the teeth.
- Pediatric Dentistry: Dental care tailored specifically for infants, children, and adolescents.
- Prosthodontics: Focuses on the restoration and replacement of missing teeth and other oral structures, often involving crowns, bridges, and dentures.
- Endodontics: Deals with the diagnosis and treatment of diseases or injuries to the dental pulp, commonly known as root canal therapy.
- Orthodontics: Specializes in correcting misaligned teeth and jaws to improve function and aesthetics.
AI Analysis | Feedback
Park Dental Partners (PARK)
Park Dental Partners, as a dental resource organization, derives its revenues primarily from the dental services provided by its affiliated general and multi-specialty dental practices directly to patients. Therefore, the major customers of Park Dental Partners are individuals who receive dental care. These customers can be categorized as follows:
- Patients with private insurance plans.
- Patients with government insurance plans (e.g., Medicaid, Medicare Advantage plans).
- Patients who pay for their dental services directly, often on an out-of-pocket basis.
AI Analysis | Feedback
AI Analysis | Feedback
Pete Swenson
Chairman and Chief Executive Officer
Pete Swenson serves as Chairman and Chief Executive Officer of Park Dental Partners, Inc. He has over two decades of leadership experience, during which he has overseen the growth of the organization from 98 to more than 200 doctors and 1,400 team members. Under his leadership, Park Dental Partners became a publicly traded company on NASDAQ in December 2025. Previously, Mr. Swenson was the Vice President of Market Development for American Dental Partners (ADPI), a dental practice management company, where he helped grow ADPI from a startup to over $300 million in revenues through its 1998 IPO. ADPI is now owned by Heartland Dental. He also serves as chair of the PDPI board and on the Park Dental Partners Foundation board.
Christopher Bernander
Chief Financial Officer
Christopher Bernander is the Chief Financial Officer for Park Dental Partners, Inc. In this role, he is responsible for managing the company's accounting, treasury, internal control, financial planning and analysis, and revenue cycle operations. Mr. Bernander joined the company in 2022, bringing experience from previous CFO and financial leadership roles in technology and professional services companies, including Calabrio, Digital River, and Renaissance Learning. He has observed a significant shift in the dental industry towards new ownership structures, where private equity firms and other investors can participate in the economic benefits and growth of dental businesses.
Jean Lind
Chief Administrative Officer
Jean Lind serves as Chief Administrative Officer for Park Dental Partners, Inc. She is responsible for managing resources related to quality assurance and compliance, patient experience, team relations, recruitment, marketing, and clinical mentor teams. A 44-year veteran of Park Dental Partners, Ms. Lind has held numerous leadership positions within the organization. She began her career as a dental hygienist and helped establish the Park Dental Partners Foundation in 2015, where she now serves as its board president.
Dr. Christopher E. Steele D.D.S.
Chief Clinical Officer, General Practices
Dr. Christopher E. Steele is the Chief Clinical Officer for General Practices at Park Dental Partners, Inc. He oversees clinical standards and practices, ensuring high-quality patient care across all affiliated general dental practices. Dr. Steele also leads continuing education and professional development initiatives for general dentists. He previously served as President of Park Dental and is appointed to the board of Park Dental Partners.
Dr. Alan Siems Law D.D.S., Ph.D.
Chief Clinical Officer of Specialty Practices & Director
Dr. Alan Siems Law serves as the Chief Clinical Officer of Specialty Practices and is a Director at Park Dental Partners, Inc. He previously held the position of President of The Dental Specialists and has been appointed to the board of Park Dental Partners.
AI Analysis | Feedback
The key risks to Park Dental Partners' business include:
-
Dependence on Third-Party Payors and Patient Price Sensitivity: A significant majority of Park Dental Partners' revenue (approximately 91-93%) is derived from patients with private insurance or government-sponsored plans. Changes in reimbursement rates, coverage policies, or administrative burdens from these third-party payors could materially impact the company's financial performance. Additionally, dental care patients are described as price-sensitive, often paying a substantial portion of their expenses out-of-pocket. Economic downturns or increased out-of-pocket costs could lead to patients deferring or foregoing dental services, thereby reducing revenue.
-
Geographic Concentration: Park Dental Partners operates its network of affiliated dental practices exclusively throughout Minnesota and Wisconsin. This geographic concentration exposes the company to regional economic downturns, adverse changes in state-specific healthcare regulations, or other local market conditions that could disproportionately affect its operations and financial results.
-
Attraction and Retention of Dental Professionals: The company's business model relies on attracting and retaining qualified dentists, hygienists, dental assistants, and patient care coordinators for its affiliated practices. While Park Dental Partners believes its dentist-majority ownership model helps with attraction and retention, there is an inherent risk in the healthcare industry of shortages of skilled professionals or increased competition for talent, which could impact the capacity and service delivery of its affiliated practices and consequently affect the company's growth and profitability.
AI Analysis | Feedback
AI Analysis | Feedback
AI Analysis | Feedback
Park Dental Partners expects several key drivers to contribute to its future revenue growth over the next 2-3 years:
- Organic expansion through opening de novo practices: The company plans to open new practice locations with its affiliated dentists in existing or new markets, which directly contributes to expanding its operational footprint and patient reach.
- Acquisition of existing practices: Park Dental Partners has a history of acquiring existing practices and expects this strategy to continue as a means of growth.
- Expansion of existing general and multi-specialty dental brands: The organization aims to expand its current general and multi-specialty dental brands, suggesting an increase in services or patient volume within its established network.
- Attracting and retaining dental professionals: The company believes its unique model, which provides significant input and enhanced stewardship for dentists, will assist in attracting and retaining dental professionals, serving as a catalyst for future growth by enabling more patients to be served and potentially broadening service offerings.
AI Analysis | Feedback
Share Issuance
- Park Dental Partners completed its Initial Public Offering (IPO) on December 3, 2025, issuing 1,535,000 shares of its common stock at $13.00 per share.
- The gross proceeds from this IPO amounted to approximately $20 million.
- The company granted underwriters a 30-day option to purchase up to an additional 230,250 shares at the public offering price.
Inbound Investments
- Approximately $20 million was raised through the company's initial public offering in December 2025 from public shareholders.
- The company's model is structured to avoid funding by private equity firms.
Outbound Investments
- Since its IPO in December 2025, Park Dental Partners has acquired two general dentistry practices.
- A portion of the IPO proceeds is designated for future practice acquisitions.
Capital Expenditures
- The company plans to utilize IPO proceeds for capital expenditures.
- These capital expenditures are intended for expanding its affiliated practice footprint and operational infrastructure across the Upper Midwest.
Peer Outperformance in Health Care Facilities
null| Industry | Names | 1Y med | 3Y med | 5Y med | Top 3 by 5Y |
|---|---|---|---|---|---|
| Health Care Distributors | 6 | 16.2% | 43.2% | 90.1% | CAH 392% · MCK 346% · COR 168% |
| Managed Health Care | 8 | 40.4% | -5.3% | 2.3% | OSCR 84% · HQY 56% · ELV 17% |
| Health Care Services | 20 | 21.1% | 37.6% | -0.3% | HIMS 239% · RDNT 173% · DGX 76% |
| Health Care Facilities ← | 24 | 6.0% | 6.5% | -4.5% | NHC 271% · THC 261% · ENSG 129% |
| Health Care Equipment | 50 | -2.7% | -0.2% | -21.1% | POCI 11050% · UFPT 341% · GKOS 222% |
| Pharmaceuticals | 62 | -10.5% | 14.8% | -38.6% | LQDA 2472% · INDV 1099% · ETON 1051% |
| Health Care Supplies | 12 | 14.1% | -8.9% | -39.7% | LNTH 287% · HAE 54% · MMSI 20% |
| Life Sciences Tools & Services | 109 | 4.3% | -11.3% | -68.4% | SNWV 1757% · MEDP 231% · NTRA 199% |
| Health Care Technology | 21 | -25.8% | -52.6% | -79.2% | SPOK 68% · HSTM 3% · VEEV -13% |
| Biotechnology | 364 | 0.6% | -21.7% | -79.4% | CELZ 1280% · DNTH 1221% · ELVN 1069% |
Research & Analysis
Invest in Strategies
Wealth Management
Peer Comparisons
| Peers to compare with: |
Financials
| Median | |
|---|---|
| Name | |
| Mkt Price | 23.35 |
| Mkt Cap | 3.8 |
| Rev LTM | 3,643 |
| Op Inc LTM | 297 |
| FCF LTM | 248 |
| FCF 3Y Avg | 356 |
| CFO LTM | 319 |
| CFO 3Y Avg | 506 |
Growth & Margins
| Median | |
|---|---|
| Name | |
| Rev Chg LTM | 6.5% |
| Rev Chg 3Y Avg | 3.1% |
| Rev Chg Q | 5.1% |
| QoQ Delta Rev Chg LTM | 1.3% |
| Op Inc Chg LTM | 0.9% |
| Op Inc Chg 3Y Avg | 2.0% |
| Op Mgn LTM | 5.7% |
| Op Mgn 3Y Avg | 7.5% |
| QoQ Delta Op Mgn LTM | 0.1% |
| CFO/Rev LTM | 8.8% |
| CFO/Rev 3Y Avg | 10.8% |
| FCF/Rev LTM | 4.0% |
| FCF/Rev 3Y Avg | 7.9% |
Price Behavior
| 1M | 2M | 3M | 6M | 1Y | 3Y | |
|---|---|---|---|---|---|---|
| Beta | 1.13 | 0.72 | 0.54 | 0.47 | -0.14 | -0.21 |
| Up Beta | 1.78 | 1.69 | 1.84 | 1.13 | -0.35 | -0.62 |
| Down Beta | 4.89 | 2.14 | 0.48 | -0.09 | -0.16 | -1.64 |
| Up Capture | 141% | 4% | 21% | 39% | 91% | 9% |
| Bmk +ve Days | 10 | 21 | 32 | 68 | 138 | 427 |
| Stock +ve Days | 10 | 19 | 31 | 62 | 97 | 97 |
| Down Capture | -169% | -19% | -11% | 37% | 19% | 11% |
| Bmk -ve Days | 11 | 21 | 32 | 59 | 113 | 324 |
| Stock -ve Days | 11 | 23 | 33 | 64 | 87 | 87 |
[1] Upside and downside betas calculated using positive and negative benchmark daily returns respectively
Based On 1-Year Data
| Annualized Return | Annualized Volatility | Sharpe Ratio | Correlation with PARK | |
|---|---|---|---|---|
| PARK | 99.0% | 77.2% | 1.46 | - |
| Sector ETF (XLV) | 24.4% | 16.1% | 1.16 | 2.2% |
| Equity (SPY) | 16.9% | 12.9% | 0.94 | 8.8% |
| Gold (GLD) | 19.1% | 29.3% | 0.60 | 2.4% |
| Commodities (DBC) | 46.3% | 20.6% | 1.73 | 0.2% |
| Real Estate (VNQ) | 4.9% | 13.6% | 0.10 | 1.4% |
| Bitcoin (BTCUSD) | -30.6% | 44.3% | -0.70 | -0.9% |
Smart multi-asset allocation framework can stack odds in your favor. Learn How
Based On 5-Year Data
| Annualized Return | Annualized Volatility | Sharpe Ratio | Correlation with PARK | |
|---|---|---|---|---|
| PARK | 14.7% | 77.2% | 1.46 | - |
| Sector ETF (XLV) | 6.4% | 15.2% | 0.24 | 2.2% |
| Equity (SPY) | 12.9% | 17.2% | 0.57 | 8.8% |
| Gold (GLD) | 19.1% | 18.8% | 0.83 | 2.4% |
| Commodities (DBC) | 11.2% | 19.5% | 0.45 | 0.2% |
| Real Estate (VNQ) | 1.1% | 18.8% | -0.05 | 1.4% |
| Bitcoin (BTCUSD) | 12.5% | 52.5% | 0.42 | -0.9% |
Smart multi-asset allocation framework can stack odds in your favor. Learn How
Based On 10-Year Data
| Annualized Return | Annualized Volatility | Sharpe Ratio | Correlation with PARK | |
|---|---|---|---|---|
| PARK | 7.1% | 77.2% | 1.46 | - |
| Sector ETF (XLV) | 10.6% | 16.7% | 0.51 | 2.2% |
| Equity (SPY) | 15.1% | 18.0% | 0.72 | 8.8% |
| Gold (GLD) | 12.1% | 16.4% | 0.61 | 2.4% |
| Commodities (DBC) | 8.3% | 18.1% | 0.37 | 0.2% |
| Real Estate (VNQ) | 4.4% | 20.7% | 0.18 | 1.4% |
| Bitcoin (BTCUSD) | 62.6% | 66.2% | 1.02 | -0.9% |
Smart multi-asset allocation framework can stack odds in your favor. Learn How
Recent Forward Guidance
Updated 8/13/2026Latest: Q2 2026 Earnings Reported 8/12/2026
| Forward Guidance | Guidance Change | |||||||
|---|---|---|---|---|---|---|---|---|
| Metric | Source | Low | Mid | High | % Chg | % Delta | Change | Prior |
| 2026 Revenue | Reported | 256.00 Mil | 258.00 Mil | 260.00 Mil | 0.8% | Raised | Guidance: 256.00 Mil for 2026 | |
| 2026 Organic Revenue Growth | Reported | 3.5% | 4.25% | 5.0% | 0 | Affirmed | Guidance: 4.25% for 2026 | |
| 2026 Adjusted EBITDA | Reported | 21.00 Mil | 22.00 Mil | 23.00 Mil | 0 | Affirmed | Guidance: 22.00 Mil for 2026 | |
| 2026 Adjusted EBITDA margin | Reported | 8.2% | 8.5% | 8.8% | -0.1% | Lowered | Guidance: 8.6% for 2026 | |
Prior: Q1 2026 Earnings Reported 5/13/2026
| Forward Guidance | Guidance Change | |||||||
|---|---|---|---|---|---|---|---|---|
| Metric | Source | Low | Mid | High | % Chg | % Delta | Change | Prior |
| 2026 Revenue | Reported | 254.00 Mil | 256.00 Mil | 258.00 Mil | 0 | Affirmed | Guidance: 256.00 Mil for 2026 | |
| 2026 Same Practice Revenue Growth | Reported | 3.5% | 4.25% | 5.0% | 0 | Affirmed | Guidance: 4.25% for 2026 | |
| 2026 Adjusted EBITDA | Reported | 21.00 Mil | 22.00 Mil | 23.00 Mil | 0 | Affirmed | Guidance: 22.00 Mil for 2026 | |
| 2026 Adjusted EBITDA margin | Reported | 8.3% | 8.6% | 8.9% | 0 | Affirmed | Guidance: 8.6% for 2026 | |
Insider Activity
Updated 8/25/2026| # | Owner | Title | Holding | Action | Filing Date | Price | Shares | Transacted Value | Value of Held Shares | Form |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Smith, Christopher Charles | Direct | Buy | 12032025 | 13.00 | 7,692 | 99,996 | 136,396 | Form | |
| 2 | Smith, Philip Irving | Direct | Buy | 12032025 | 13.00 | 769 | 9,997 | 46,397 | Form | |
| 3 | Law, Alan Siems | Direct | Buy | 12032025 | 13.00 | 1,923 | 24,999 | 2,353,533 | Form | |
| 4 | Gerlach, Todd Christopher | Direct | Buy | 12032025 | 13.00 | 7,692 | 99,996 | 895,011 | Form | |
| 5 | Bernander, Christopher James | Chief Financial Officer | Direct | Buy | 12032025 | 13.00 | 1,923 | 24,999 | 724,828 | Form |
| # | Owner | Title | Holding | Action | Filing Date | Price | Shares | Transacted Value | Value of Held Shares | Form |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Smith, Christopher Charles | Direct | Buy | 12032025 | 13.00 | 7,692 | 99,996 | 136,396 | Form | |
| 2 | Smith, Philip Irving | Direct | Buy | 12032025 | 13.00 | 769 | 9,997 | 46,397 | Form | |
| 3 | Law, Alan Siems | Direct | Buy | 12032025 | 13.00 | 1,923 | 24,999 | 2,353,533 | Form | |
| 4 | Gerlach, Todd Christopher | Direct | Buy | 12032025 | 13.00 | 7,692 | 99,996 | 895,011 | Form | |
| 5 | Bernander, Christopher James | Chief Financial Officer | Direct | Buy | 12032025 | 13.00 | 1,923 | 24,999 | 724,828 | Form |
| 6 | Swenson, Peter G | CEO and Chairman | Direct | Buy | 12032025 | 13.00 | 3,846 | 49,998 | 3,107,754 | Form |
External Quote Links
| Y Finance | Barrons |
| TradingView | Morningstar |
| SeekingAlpha | ValueLine |
| Motley Fool | Robinhood |
| CNBC | Etrade |
| MarketWatch | Unusual Whales |
| YCharts | Perplexity Finance |
| FinViz |
Prefer one of these to Trefis? Tell us why.